Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2024Frontiers in PharmacologyOpen Access

Impact of SGLT2 inhibitors on lower limb complications: a mendelian randomization perspective

View Full Paper
Ask AI
Bookmark
Share

Authors

BCBaixing ChenAO FoundationMHMingling HuangBPBin PuSuzhou Traditional Chinese Medicine Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e5832cb6db6435875205c6https://doi.org/10.3389/fphar.2024.1401103
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary2022 · 87 citations
  2. 2Exome sequencing and analysis of 454,787 UK Biobank participants2021 · 1,094 citations
  3. 3The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management2022 · 176 citations
  4. 4Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials2021 · 148 citations
  5. 5Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes2018 · 166 citations